Kevan E. Clemens
Geen lopende functies
Profiel
Kevan E.
Clemens formerly worked at Kosan Biosciences, Inc., as Director from 2005 to 2008, Ivory Capital Corp., as Director, Chelsea Therapeutics International Ltd., as Independent Director from 2012 to 2014, MEI Pharma, Inc., as Independent Non-Executive Director from 2014 to 2021, Hoffmann-La Roche, Inc., as Executive Vice President & Business Director, Specialty Care, Inc., as Vice President, and de Syntex & Roche SA de CV, as Head-Pharmacoeconomics & Pricing.
Dr. Clemens received his doctorate degree from University College London.
Eerdere bekende functies van Kevan E. Clemens
Bedrijven | Functie | Einde |
---|---|---|
MEI PHARMA, INC. | Director/Board Member | 22-11-2021 |
CHELSEA THERAPEUTICS INTERNATIONAL LTD. | Chairman | 11-07-2012 |
Kosan Biosciences, Inc.
Kosan Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Kosan Biosciences, Inc. develops drugs for cancer therapeutics. The company was founded in 1995 and is headquartered in New York, NY. | Director/Board Member | 26-06-2008 |
Ivory Capital Corp. | Director/Board Member | 02-08-2005 |
Hoffmann-La Roche, Inc.
Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Corporate Officer/Principal | 01-01-2004 |
Opleiding van Kevan E. Clemens
University College London | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
MEI PHARMA, INC. | Health Technology |
Bedrijven in privébezit | 6 |
---|---|
Kosan Biosciences, Inc.
Kosan Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Kosan Biosciences, Inc. develops drugs for cancer therapeutics. The company was founded in 1995 and is headquartered in New York, NY. | Health Technology |
Ivory Capital Corp. | Finance |
Chelsea Therapeutics International Ltd.
Chelsea Therapeutics International Ltd. BiotechnologyHealth Technology Chelsea Therapeutics International Ltd. acquires, develops and commercializes innovative products for the treatment of a variety of human diseases. The company was founded by Simon C. Pedder on June 17, 2005 and is headquartered in Charlotte, NC. | Health Technology |
Hoffmann-La Roche, Inc.
Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Health Technology |
Specialty Care, Inc.
Specialty Care, Inc. Hospital/Nursing ManagementHealth Services Specialty Care, Inc. provides retirement and nursing services. The private company is based in Vaughan, Canada. | Health Services |
de Syntex & Roche SA de CV |